Marshall Wace’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Marshall Wace’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-507,781	Closed	-$16.9M	–	3145
2024 Q3	$16.9M	Buy	507,781 +45,158	+10%	+$1.55M	0.02%	571
2024 Q2	$12.5M	Sell	462,623 -103,875	-18%	-$2.05M	0.02%	639
2024 Q1	$12.2M	Buy	+566,498	New	+$12.4M	0.02%	680

Marshall Wace's LBPH Position: Q4 2024 in Review

Marshall Wace sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 507,781 shares — an estimated $16.9M sold.

Marshall Wace first reported a position in LBPH in Q1 2024 and held it in 3 quarters. The position peaked at $16.9M in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Marshall Wace reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Marshall Wace sold 507,781 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $16.9M.
Marshall Wace first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 3 quarters.
Marshall Wace's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $16.9M in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Marshall Wace's 13F filing for Q4 2024, filed 13 Feb 2025.